| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 145, 541-549, Copyright © 1994 by American Society for Investigative Pathology
REGULAR ARTICLES |
S Takata, A Papayianni, M Matsubara, W Jimenez, PH Pronovost and HR Brady
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
15-hydroxyeicosatetraenoic acid (15-HETE) is an eicosanoid, formed by the actions of 15-lipoxygenase, epoxygenases, and cyclooxygenases on arachidonic acid, whose tissue levels are often elevated during inflammation. The present study demonstrates that 15(S)-HETE is a potent inhibitor of polymorphonuclear neutrophil (PMN) migration across cytokine-activated endothelium in vitro. 15(S)-HETE is rapidly esterified into PMN phospholipids, and we report that 15-(S)-HETE- remodeled PMN displayed blunted adhesion to, and migration across, human endothelial cells that had been activated with either interleukin- 1 beta or tumor necrosis factor-alpha Several lines of evidence suggested that 15(S)-HETE inhibited PMN transmigration by attenuating PMN responsiveness to endothelial cell-derived platelet-activating factor (PAF). The inhibitory action of 15(S)-HETE on transmigration was not restricted by the profile of adhesion molecules expressed by cytokine-activated endothelium. Interleukin-1 beta and tumor necrosis factor-alpha induce PAF production by endothelium, and PMN migration across cytokine-activated endothelium was inhibited by a PAF receptor antagonist. PMN migration across endothelium in response to exogenous PAF was dramatically inhibited following exposure of PMN to 15(S)-HETE. Furthermore, 15(S)-HETE-remodeled PMN displayed impaired cytoskeletal and adhesion responses when stimulated by exogenous PAF, two pivotal events in PMN migration across activated endothelium. 15(S)-HETE seemed to attenuate PMN responsiveness to PAF by inhibiting membrane- associated signal transduction events. In keeping with this interpretation, remodeling of PMN phospholipids with 15(S)-HETE was associated with a sixfold reduction in the affinity of specific high- affinity PAF receptors for their ligand and impaired PAF-triggered IP3 generation. In contrast, PMN adhesion responses stimulated by calcium ionophore or activators of protein kinase C remained intact. These results provide further evidence that 15(S)-HETE may be an important endogenous inhibitor of PMN-endothelial cell interaction that serves to limit or reverse neutrophil-mediated inflammation in vivo.
This article has been cited by other articles:
![]() |
C. G. Freire-de-Lima, Y. Q. Xiao, S. J. Gardai, D. L. Bratton, W. P. Schiemann, and P. M. Henson Apoptotic Cells, through Transforming Growth Factor-beta, Coordinately Induce Anti-inflammatory and Suppress Pro-inflammatory Eicosanoid and NO Synthesis in Murine Macrophages J. Biol. Chem., December 15, 2006; 281(50): 38376 - 38384. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chanez, C. Bonnans, C. Chavis, and I. Vachier 15-Lipoxygenase: A Janus Enzyme? Am. J. Respir. Cell Mol. Biol., December 1, 2002; 27(6): 655 - 658. [Full Text] [PDF] |
||||
![]() |
M. E. KRAWIEC, J. Y. WESTCOTT, H. W. CHU, S. BALZAR, J. B. TRUDEAU, L. B. SCHWARTZ, and S. E. WENZEL Persistent Wheezing in Very Young Children Is Associated with Lower Respiratory Inflammation Am. J. Respir. Crit. Care Med., May 1, 2001; 163(6): 1338 - 1343. [Abstract] [Full Text] |
||||
![]() |
U. P.Kelavkar, C. Cohen, H. Kamitani, T. E.Eling, and K. F.Badr Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging Carcinogenesis, October 1, 2000; 21(10): 1777 - 1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Profita, A. Sala, L. Riccobono, E. Pace, A. Paterno, S. Zarini, L. Siena, A. Mirabella, G. Bonsignore, and A. M. Vignola 15(S)-HETE modulates LTB4 production and neutrophil chemotaxis in chronic bronchitis Am J Physiol Cell Physiol, October 1, 2000; 279(4): C1249 - C1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Munger, A. Montero, M. Fukunaga, S. Uda, T. Yura, E. Imai, Y. Kaneda, J. M. Valdivielso, and K. F. Badr Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis PNAS, November 9, 1999; 96(23): 13375 - 13380. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Heydeck, L. Thomas, K. Schnurr, F. Trebus, W. E. Thierfelder, J. N. Ihle, and H. Kuhn Interleukin-4 and -13 Induce Upregulation of the Murine Macrophage 12/15-Lipoxygenase Activity: Evidence for the Involvement of Transcription Factor STAT6 Blood, October 1, 1998; 92(7): 2503 - 2510. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Mancini, P. J. Vickers, G. P. O'Neill, C. Boily, J.-P. Falgueyret, and D. Riendeau Altered Sensitivity of Aspirin-Acetylated Prostaglandin G/H Synthase-2 to Inhibition by Nonsteroidal Anti-Inflammatory Drugs Mol. Pharmacol., January 1, 1997; 51(1): 52 - 60. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |